Gynecologic Oncology Group: Endometrial Neoplasms trials

The registry lists 24 Endometrial Neoplasms studies with Gynecologic Oncology Group as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 12Phase 3 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial CancerStatus unknownNCT02065687Phase 2/3Results posted
• Abemaciclib and Letrozole to Treat Endometrial CancerActive, not recruitingNCT04393285Phase 2
• Prognostic Biomarkers in Patients With Endometrial CancerCompletedNCT01208467
• Biomarkers in Samples From Patients With Endometrial CancerWithdrawnNCT01199250
• Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial CancerCompletedNCT01198171
• Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial CancerStatus unknownNCT01150682
• Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial CancerStatus unknownNCT01119573
• Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
• Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00087100Phase 2
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)CompletedNCT00085332Phase 2
• Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00071929Phase 2
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00023894Phase 2
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
• Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00005861Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005840Phase 1
• Chemotherapy in Treating Patients With Sarcoma of the UterusCompletedNCT00005643Phase 2
• Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial CancerCompletedNCT00005031Phase 2
• Danazol in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00003946Phase 2
• Quality of Life in Survivors of Gynecologic CancerCompletedNCT00003795
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
• Surgery Plus Medroxyprogesterone in Preventing Endometrial CancerTerminatedNCT00003179Phase 2
• Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial CancerTerminatedNCT00002976Phase 3
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerCompletedNCT00002493Phase 3